In the last trading session, 0.43 million shares of the Neuraxis Inc (AMEX:NRXS) were traded, and its beta was 3.55. Most recently the company’s share price was $3.03, and it changed around $0.0 or 0.00% from the last close, which brings the market valuation of the company to $21.88M. NRXS currently trades at a discount to its 52-week high of $6.20, offering almost -104.62% off that amount. The share price’s 52-week low was $1.33, which indicates that the current value has risen by an impressive 56.11% since then.

Neuraxis Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended NRXS as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.

Neuraxis Inc (AMEX:NRXS) trade information

The performance over the last five days has remained in the green territory. The rise to weekly highs of 6.20 on recent trading dayincreased the stock’s daily price by 51.13%. The company’s shares are currently up 28.94% year-to-date, but still up 34.67% over the last five days. On the other hand, Neuraxis Inc (AMEX:NRXS) is 27.04% up in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -14.82%.

NRXS Dividends

Neuraxis Inc’s next quarterly earnings report is expected to be released in June.

Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 18.98 shares worth $57515.0, making up 0.26% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 17.75 shares worth around $53767.0, which represents about 0.25% of the total shares outstanding.